Activest Wealth Management’s Editas Medicine EDIT Stock Holding History

Activest Wealth Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$10.3K	Hold	4,000	–	–	﹤0.01%	575
2026 Q2	$13K	Hold	4,000	–	–	﹤0.01%	532
2026 Q1	$9.9K	Hold	4,000	–	–	﹤0.01%	687
2025 Q4	$8.2K	Hold	4,000	–	–	﹤0.01%	700
2025 Q3	$13.9K	Hold	4,000	–	–	﹤0.01%	432
2025 Q2	$8.8K	Hold	4,000	–	–	﹤0.01%	456
2025 Q1	$4.64K	Hold	4,000	–	–	﹤0.01%	511
2024 Q4	$5.08K	Hold	4,000	–	–	﹤0.01%	373
2024 Q3	$13.6K	Hold	4,000	–	–	﹤0.01%	286
2024 Q2	$18.7K	Buy	+4,000	New	+$22.6K	0.01%	243

Other funds holding EDIT

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Joel Isaacson & Co New York $3.5B AUM 17.42% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

Thrive Wealth Management Audubon, Pennsylvania $805M AUM 17.78% 1-Year Est. Return

Activest Wealth Management's EDIT Position: Q3 2026 in Review

Activest Wealth Management held its Editas Medicine (EDIT) position steady in Q3 2026 at 4,000 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #575.

Activest Wealth Management first reported a position in EDIT in Q2 2024 and has held it in 10 quarters since. The position peaked at $18.7K in Q2 2024. 71 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.

Activest Wealth Management held 4,000 shares of Editas Medicine worth $10.3K as of Q3 2026.
Activest Wealth Management left its Editas Medicine share count unchanged in Q3 2026.
Editas Medicine made up ﹤0.01% of Activest Wealth Management's portfolio in Q3 2026, its #575 holding.
Activest Wealth Management first reported a position in Editas Medicine in Q2 2024 and has held it in 10 quarters since.
Activest Wealth Management's Editas Medicine position peaked at $18.7K in Q2 2024.
71 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.